Related references
Note: Only part of the references are listed.Clinical and Genetic Implications of Mutation Burden in Squamous Cell Carcinoma of the Lung
Tatsuro Okamoto et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Implementation of clinical sequencing in cancer genome medicine in Japan
Takashi Kohno
CANCER SCIENCE (2018)
Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid Tumors
Jeffrey M. Conroy et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2018)
Impact of Concurrent Genomic Alterations Detected by Comprehensive Genomic Sequencing on Clinical Outcomes in East-Asian Patients with EGFR-Mutated Lung Adenocarcinoma
Seijiro Sato et al.
SCIENTIFIC REPORTS (2018)
Common driver mutations and smoking history affect tumor mutation burden in lung adenocarcinoma
Masayuki Nagahashi et al.
JOURNAL OF SURGICAL RESEARCH (2018)
HER kinase inhibition in patients with HER2-and HER3-mutant cancers
David M. Hyman et al.
NATURE (2018)
Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS
Esko A. Kautto et al.
ONCOTARGET (2017)
Utility of comprehensive genomic sequencing for detecting HER2-positive colorectal cancer
Yoshifumi Shimada et al.
HUMAN PATHOLOGY (2017)
Formalin-fixed paraffin-embedded sample conditions for deep next generation sequencing
Masayuki Nagahashi et al.
JOURNAL OF SURGICAL RESEARCH (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Clinical application of a cancer genomic profiling assay to guide precision medicine decisions
Cheryl Eifert et al.
PERSONALIZED MEDICINE (2017)
Hypermutation and microsatellite instability in gastrointestinal cancers
Kizuki Yuza et al.
ONCOTARGET (2017)
Actionable gene-based classification toward precision medicine in gastric cancer
Hiroshi Ichikawa et al.
GENOME MEDICINE (2017)
Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial
Kiyotaka Yoh et al.
LANCET RESPIRATORY MEDICINE (2017)
Clinical sequencing using a next-generation sequencing-based multiplex gene assay in patients with advanced solid tumors
Tadayuki Kou et al.
CANCER SCIENCE (2017)
Novel combination of serum microRNA for detecting breast cancer in the early stage
Akihiko Shimomura et al.
CANCER SCIENCE (2016)
Clinical Implementation of Novel Targeted Therapeutics in Advanced Breast Cancer
Mary D. Chamberlin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Cancer Genomics: Diversity and Disparity Across Ethnicity and Geography
Daniel S. W. Tan et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Classification and characterization of microsatellite instability across 18 cancer types
Ronald J. Hanse et al.
NATURE MEDICINE (2016)
Aiming High - Changing the Trajectory for Cancer
Douglas R. Lowy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine
Masayuki Nagahashi et al.
GENOME MEDICINE (2016)
The genomics and therapeutics of HER2-positive gastric cancer-from trastuzumab and beyond
Ciara M. Kelly et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Clinical Application of Targeted Next Generation Sequencing for Colorectal Cancers
Quitterie Fontanges et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Pre-Analytical Considerations for Successful Next-Generation Sequencing (NGS): Challenges and Opportunities for Formalin-Fixed and Paraffin-Embedded Tumor Tissue (FFPE) Samples
Gladys Arreaza et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation
Lori E. Lowes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Standardization and quality management in next-generation sequencing
Christoph Endrullat et al.
APPLIED AND TRANSLATIONAL GENOMICS (2016)
Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP Inhibitors
Christopher J. Lord et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer
Jordan Lerner-Ellis et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2015)
Next-generation sequencing (NGS) in metastatic breast cancer (mBC) patients: Translation from sequence data into clinical practice.
Raphael Brandao Moreira et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Association of PIK3CA mutation with response (ExRx) to cetuximab (C) in metastatic (met) triple-negative breast cancer (TNBC).
Joyce O'Shaughnessy et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The genomic landscape of response to EGFR blockade in colorectal cancer
Andrea Bertotti et al.
NATURE (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A New Initiative on Precision Medicine
Francis S. Collins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Cancer whole-genome sequencing: present and future
H. Nakagawa et al.
ONCOGENE (2015)
Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue
Danielle Mercatante Carrick et al.
PLOS ONE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Hypermutation takes the driver's seat
Matthias Schlesner et al.
GENOME MEDICINE (2015)
Clinical Next-Generation Sequencing in Patients with Non-Small Cell Lung Cancer
Ian S. Hagemann et al.
CANCER (2015)
Sequence Artifacts in DNA from Formalin-Fixed Tissues: Causes and Strategies for Minimization
Hongdo Do et al.
CLINICAL CHEMISTRY (2015)
The Impact of Concomitant Genomic Alterations on Treatment Outcome for Trastuzumab Therapy in HER2-Positive Gastric Cancer
Ji Yun Lee et al.
SCIENTIFIC REPORTS (2015)
Development of trastuzumab-resistant human gastric carcinoma cell lines and mechanisms of drug resistance
Qiang Zuo et al.
SCIENTIFIC REPORTS (2015)
Triple-negative breast cancer in African-American women: disparities versus biology
Eric C. Dietze et al.
NATURE REVIEWS CANCER (2015)
Somatic Mutations in MLH1 and MSH2 Are a Frequent Cause of Mismatch-Repair Deficiency in Lynch Syndrome-Like Tumors
Arjen R. Mensenkamp et al.
GASTROENTEROLOGY (2014)
Reading between the lines; understanding drug response in the post genomic era
Constantine C. Alifrangis et al.
MOLECULAR ONCOLOGY (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes
Tae-Min Kim et al.
CELL (2013)
Lessons from the Cancer Genome
Levi A. Garraway et al.
CELL (2013)
The Effect of Aging of Formalin-fixed Paraffin-embedded Tissues on the In Situ Hybridization and Immunohistochemistry Signals in Cervical Lesions
Allison J. Nuovo et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2013)
From human genome to cancer genome: The first decade
David A. Wheeler et al.
GENOME RESEARCH (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers
Steven A. Roberts et al.
NATURE GENETICS (2013)
Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
Ron Bose et al.
CANCER DISCOVERY (2013)
Overcoming resistance and restoring sensitivity to HER2-targeted therapies in breast cancer
M. S. N. Mohd Sharial et al.
ANNALS OF ONCOLOGY (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer
Katrien Berns et al.
CANCER CELL (2007)
Share Paper
